03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Rare diseases
Michael Sumner
Chief Medical Officer, Inovio
press citation on 1 topic since 2 Nov 2026 · last quoted 2 Nov 2026
02 Quoted on · 1 of 29 topics
Michael Sumner: key facts
- Kind of voice
- Sector leader
- Role
- Chief Medical Officer, Inovio
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 2 Nov 2026
04 The signal · where Michael Sumner sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Isa HouwinkClinicianM.D., Ph.D., Mayo Clinic family medicine physician and senior author of the study1
- 49=Jacqueline SheaAcademicPh.D., CEO of Inovio1
- 49=Michael SumnerSector leaderChief Medical Officer, Inovio1
- 49=Nathaniel MillerClinicianM.D., Mayo Clinic family medicine physician and first author of the study1
- 49=Frederick KaplanAcademicProfessor of molecular orthopedics, University of Pennsylvania Perelman School of Medicine1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Michael Sumner has said
- fiercepharma.com1
Where Michael Sumner has been quoted
- 01Inovio's DNA-based immunotherapy Voceryq approved by FDA for rare HPV airway diseasefiercepharma.com · 2 Nov 2026
Verbatim
“These straightforward distribution requirements should facilitate flexibility in the administration location, including the doctor's office.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.